MedTrace Logo

Evaluation of Galectin-3 in Serum and Saliva of Pemphigus Patients

NCT05992727 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-08-15

No results posted yet for this study

Summary

Assessment of the expression of galectin-3 in serum and saliva of pemphigus patients and compare it with age and sex matched controls. We want to detect whether a correlation exists between galectin-3 level in serum, as well as saliva and disease activity score by Autoimmune Bullous Skin Disorder Intensity Score (ABSIS).

Conditions

  • Galectin-3 and Pemphigus

Interventions

DIAGNOSTIC_TEST

Galectin 3 measurement in serum and saliva by ELIZA

Galectin 3 measurement in serum and saliva by ELISA in the two groups

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-08
Primary Completion
2024-02-01
Completion
2024-03-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05992727 on ClinicalTrials.gov